Toggle navigation
Home
Search
Services
Blog
Contact
About
Chemical Synthesis
Razden, Raj K.
Raylo Chemicals, Ltd., Edmonton, AB, Canada
Search 3 grants from Raj Razden
Search grants from Raylo Chemicals, Ltd.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Modeling Multi-step Leukemogenesis Nf1 and Kras Mutant Mice
Development of Tethered Toxins for Neuroscience Research
Psychophysiological Effects of Meditation Based Stress Reduction Training in Work
Autograft Fibroblasts and Neoligament Formation
Initiation of DNA Replication in E. coli
Recently added grants:
Core C - Sequencing and Analysis.
Targeting TET1 signaling to treat acute myeloid leukemia
Targeting the Unfolded Protein Response in PanNETs
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
Augmenting Pancreatic Cancer Immunotherapy via TGF? Pathway Inhibition
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM067975-004
Application #
3614680
Study Section
Project Start
1989-01-09
Project End
Budget Start
1989-01-09
Budget End
1989-04-09
Support Year
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Raylo Chemicals, Ltd.
Department
Type
DUNS #
City
Edmonton
State
AB
Country
Canada
Zip Code
Related projects
NIH 1989
N01 CM
Chemical Synthesis
Razden, Raj K. / Raylo Chemicals, Ltd.
NIH 1988
N01 CM
Chemical Synthesis
Razden, Raj K. / Raylo Chemicals, Ltd.
NIH 1987
N01 CM
Chemical Synthesis
Razden, Raj K. / Raylo Chemicals, Ltd.
Comments
Be the first to comment on this grant